TriSalus Life Sciences (TLSIW) Return on Sales (2022 - 2026)

TriSalus Life Sciences has reported Return on Sales for 5 years, with the latest figure at 0.0% in Q1 2026.

• For the quarter ending Q1 2026, Return on Sales rose 1.0% year-over-year to 0.0%; the trailing twelve-month figure through Mar 2026 stood at 0.01% (changed 0.0% YoY), and the FY2025 full-year result was 0.01%, changed 0.0% from the prior year.
• Return on Sales for Q1 2026 stood at 0.0%, up from 0.01% in the prior quarter.
• The five-year high for Return on Sales was 0.0% in Q1 2026, with the low at 0.07% in Q4 2022.
• Historically, Return on Sales has averaged 0.02% across 5 years, with a median of 0.01% in 2025.
• Annual changes were most pronounced in 2024 — Return on Sales grew 5 bps — and 2025, when it slipped 1 bps.
• TriSalus Life Sciences' Return on Sales stood at 0.07% in 2022, then gained by 11 bps to 0.06% in 2023, then surged by 80 bps to 0.01% in 2024, then soared by 40 bps to 0.01% in 2025, then soared by 123 bps to 0.0% in 2026.
• The last three Return on Sales figures came in at 0.0% (Q1 2026), 0.01% (Q4 2025), and 0.01% (Q3 2025), per Business Quant data.